SCHEMBL302060

SCHEMBL302060

CC1OCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL732233 0.92
SCHEMBL10239392 0.89
SCHEMBL16596098 0.84 LMNA (0.36)
SCHEMBL245730 0.84
Ammonia Solution, Strong SCHEMBL3830975 0.80
Iodide SCHEMBL31361258 0.80
Ethane SCHEMBL6711452 0.80
SCHEMBL4784762 0.79
SCHEMBL15996509 0.77
SCHEMBL4872069 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1483 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12597642-B2 2026-04-07 US claimed
EP-4322279-B1 NONAQUEOUS ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME LG ENERGY SOLUTION LTD (KR) 2025-10-22 EP claimed
EP-4148853-B1 ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG ENERGY SOLUTION LTD (KR) 2025-10-08 EP claimed
CN-119233977-A Prodrugs of boron compounds and their use in the treatment of bacterial infections 上海盟科药业股份有限公司 2024-12-31 CN claimed
CN-119233823-A Method and use of boron compounds for treating nontuberculous mycobacterial infections and pharmaceutical compositions for treating the same 上海盟科药业股份有限公司 2024-12-31 CN claimed
US-20240347773-A1 NONAQUEOUS ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME LG ENERGY SOLUTION, LTD. (KR) 2024-10-17 US claimed
US-20240339601-A1 ELECTROCHEMICAL DEVICE LG ENERGY SOLUTION, LTD. (KR) 2024-10-10 US claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 EP claimed
US-20240279247-A1 PRODRUGS OF BORON COMPOUNDS AND THEIR USE IN TREATING BACTERIAL INFECTIONS MICURX PHARMACEUTICALS, INC. 2024-08-22 US claimed
US-20240269155-A1 METHODS AND USES OF BORON COMPOUNDS IN THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIUM INFECTIONS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SAME MICURX PHARMACEUTICALS, INC. 2024-08-15 US claimed
WO-1998033789-A1 SYNTHESIS OF TERFENADINE AND DERIVATIVES SEPRACOR, INC. (US) 1998-08-06 WO claimed
WO-1997013776-A2 NOVEL AMINE DERIVATIVES OF EPIPODOPHYLLOTOXIN 2', 3'-DIDEOXYGLYCOSIDES, PREPARATION METHOD THEREFOR AND USE THEREOF AS A DRUG AND FOR TREATING CANCER PIERRE FABRE MEDICAMENT (FR) 1997-04-17 WO claimed
US-5527797-A IONTOPHORESIS MACROCHEM CORPORATION (US) 1996-06-18 US claimed
EP-0138773-B1 USE OF QUINOLINE DERIVATIVES FOR THE PROTECTION OF CROP PLANTS CIBA-GEIGY AG (CH) 1990-08-29 EP claimed
EP-0131374-B1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PENEM DERIVATIVES PFIZER INC. (US) 1988-11-23 EP claimed
US-4619783-A BACTERICIDES PFIZER INC. (US) 1986-10-28 US claimed
EP-0157876-A1 HERBICIDAL 1-ARYL-$g(D)?2 -1,2,4-TRIAZOLIN-5-ONES FMC Corporation (US) 1985-10-16 EP claimed
WO-1985001637-A1 HERBICIDAL 1-ARYL-DELTA2-1,2,4-TRIAZOLIN-5-ONES FMC CORPORATION (US) 1985-04-25 WO claimed
EP-0138773-A2 Use of quinoline derivatives for the protection of crop plants CIBA-GEIGY AG (CH) 1985-04-24 EP claimed
EP-0131374-A1 Process and intermediates for the preparation of penem derivatives PFIZER INC. (US) 1985-01-16 EP claimed